Elan Pharma, FDA argue stability, solubility issues.(Elan Pharmaceuticals Corp.)(United States Food and Drug Administration)(Brief Article): An article from: Inspection Monitor

This digital document is an article from Inspection Monitor, published by Washington Information Source on April 1, 1996. The length of the article is 730 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Elan Pharma, FDA argue stability, solubility issues.(Elan Pharmaceuticals Corp.)(United States Food and Drug Administration)(Brief Article)
Publication:Inspection Monitor (Newsletter)
Date: April 1, 1996
Publisher: Washington Information Source
Volume: 1 Issue: 4 Page: NA

Article Type: Brief Article

Distributed by Thomson Gale